<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
	<channel>
		<title>Joomla! powered Site</title>
		<description>Joomla! site syndication</description>
		<link>http://www.medipacs.com</link>
		<lastBuildDate>Tue, 07 Sep 2010 03:59:43 +0100</lastBuildDate>
		<generator>FeedCreator 1.7.2</generator>
		<image>
			<url>http://www.medipacs.com/images/M_images/joomla_rss.png</url>
			<title>Powered by Joomla!</title>
			<link>http://www.medipacs.com</link>
			<description>Joomla! site syndication</description>
		</image>
		<item>
			<title>11/08 - Medipacs Chosen to present at Invest Southwest Capital Conference</title>
			<link>http://www.medipacs.com/content/view/6/2/</link>
			<description>News Release                                                       November 17, 2008                          TUCSON, AZ. &amp;mdash; Medipacs, Inc., a Tucson based drug delivery device company announces today the company has been selected to present at the Invest Southwest Capital Conference to be held in Scottsdale , AZ on December 10 and 11, 2008.                           One of only 12 companies to present at the conference, Medipacs was selected from 84 submissions in a variety of high-tech fields. &amp;ldquo;Generally speaking, (the businesses) have to be highly scalable and highly defensible&amp;rdquo; said Dave Bittner, this year&amp;#39;s conference chairman.                           Medipacs was founded in 2004 by Mark Banister, a career entrepreneur and was awarded several grants from the National Science Foundation and Science Foundation of Arizona which helped advance fundamentally new polymer science to the point of attracting investor attention. Medipacs&amp;#39; novel polymer gel expands to multiples of its original size. This large expansion ratio occurs precisely and rapidly which enables a variety of practical, low cost drug delivery devices to be used for administering small volume Parenteral (SVP) drugs. According to recent studies, SVP drugs are often implicated in drug delivery errors that extend hospital stays and increase variable costs and Medipacs devices are aimed at reducing many of these errors with its novel delivery systems.                           Since June 2007, the company has raised $1.7M from Mesa Verde Ventures, a seed stage venture firm specializing in medical device start-ups in San Diego , CA , and from angel investors in Tucson , San Diego and Washington DC . Mark McWilliams , CEO of Medipacs, has been the co-founder of two drug delivery device companies which brought new drug delivery technologies to market. He has also developed devices and systems serving other medical fields.                            Bill Bloom, V.P. Engineering, a Caltech graduate that has worked in the medical device field for over 35 years and who developed insulin pumps for Alfred Mann at Mini-Med in the 1980&amp;#39;s and then at Siemens leads the engineering effort and said: &amp;ldquo;Medipacs has developed the first truly unique infusion pump mechanism I have seen in the last 30 years and it is the most versatile, low cost mechanism for accurately metering drugs which I have ever seen or been part of commercializing. Medipacs&amp;#39; technology can disrupt and obsolete existing methods for delivery of SVP drugs.&amp;rdquo;                            About Medipacs                            Medipacs, Inc. is a Tucson based drug delivery device company with expertise in hydro gel polymers. It is developing advanced infusion technologies and is now focused on its first commercial application, a programmable disposable infusion device called a Mini-Infuser&amp;trade;. The company is located at the Arizona Center for Innovation. Please contact : Mark McWilliams 858-227-0569 MarkMcWilliams@mediapcs.com (mailto:MarkMcWilliams@mediapcs.com)                           About the Invest Southwest Capital Conference                            Invest Southwest has been connecting entrepreneurs and investors in Arizona and the Southwest for over 15 years. Companies that have presented at past Invest Southwest conferences include Ventana Medical, Flypaper, NetPro, Vivid Semiconductor, and AutoXray. Companies submitting to present seek between $250,000 and $5MM in capital. For more information about the conference, with title sponsor The Miller Group, visit www.investsouthwest.org (http://www.investsouthwest.org/).                           </description>
			<category>News - Latest</category>
			<pubDate>Wed, 07 Jul 2004 12:54:06 +0100</pubDate>
		</item>
		<item>
			<title>Welcome to Joomla!</title>
			<link>http://www.medipacs.com/content/view/1/2/</link>
			<description>If you've read anything at all about Content Management Systems (CMS), you'll probably know at least three things: CMS are the most exciting way to do business, CMS can be really, I mean really, complicated and lastly Portals are absolutely, outrageously, often unaffordably expensive. Joomla! is set to change all that ... Joomla! is different from the normal models for portal software. For a start, it's not complicated. Joomla! has been developed for the masses. It's licensed under the GNU/GPL license, easy to install and administer and reliable. Joomla! doesn't even require the user or administrator of the system to know HTML to operate it once it's up and running.</description>
			<category>News - Latest</category>
			<pubDate>Sat, 12 Jun 2004 12:54:06 +0100</pubDate>
		</item>
	</channel>
</rss>
